Centaurus Financial, Inc. Alkermes Plc. Transaction History
Centaurus Financial, Inc.
- $1.76 Billion
- Q3 2025
A detailed history of Centaurus Financial, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Centaurus Financial, Inc. holds 5,602 shares of ALKS stock, worth $162,682. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,602
Previous 4,642
20.68%
Holding current value
$162,682
Previous $132,000
27.27%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ALKS
# of Institutions
401Shares Held
176MCall Options Held
901KPut Options Held
400K-
Black Rock Inc. New York, NY29.1MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$528 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$297 Million0.03% of portfolio
-
State Street Corp Boston, MA8.54MShares$248 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY8.09MShares$235 Million1.98% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...